EPITRAN

The proposed COST action aims at fostering the development of the emerging field of epitranscriptomics in Europe. We believe that, by understanding the role of RNA modifications in physiology and pathology, novel and powerful disease biomarkers and drug targets could be identified.

Primary location: Brussels Belgium